Clinical Trial Update: Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the DTaP-HB-PRP-T combined vaccine to Tritanrix-HepB/Hib, both given concomitantly with oral polio vaccine; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• DTaP-HB-PRP-T (Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2013-12-10